These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9117258)

  • 21. Instructive niches: environmental instructions that confound NG2 proteoglycan expression and the fate-restriction of CNS progenitors.
    Sellers DL; Horner PJ
    J Anat; 2005 Dec; 207(6):727-34. PubMed ID: 16367800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: identifying a venule-specific phenotype.
    Murfee WL; Skalak TC; Peirce SM
    Microcirculation; 2005 Mar; 12(2):151-60. PubMed ID: 15824037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of interaction between NG2 proteoglycan and galectin-3.
    Wen Y; Makagiansar IT; Fukushi J; Liu FT; Fukuda MN; Stallcup WB
    J Cell Biochem; 2006 May; 98(1):115-27. PubMed ID: 16365873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed primary culture and clonal analysis provide evidence that NG2 proteoglycan-expressing cells after spinal cord injury are glial progenitors.
    Yoo S; Wrathall JR
    Dev Neurobiol; 2007 Jun; 67(7):860-74. PubMed ID: 17506499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Proteoglycans in the developing brain].
    Oohira A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):171-6. PubMed ID: 7796322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of axon growth by oligodendrocyte precursor cells.
    Chen ZJ; Ughrin Y; Levine JM
    Mol Cell Neurosci; 2002 May; 20(1):125-39. PubMed ID: 12056844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity.
    Nishiyama A; Komitova M; Suzuki R; Zhu X
    Nat Rev Neurosci; 2009 Jan; 10(1):9-22. PubMed ID: 19096367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NG2 expression regulates vascular morphology and function in human brain tumours.
    Brekke C; Lundervold A; Enger PØ; Brekken C; Stålsett E; Pedersen TB; Haraldseth O; Krüger PG; Bjerkvig R; Chekenya M
    Neuroimage; 2006 Feb; 29(3):965-76. PubMed ID: 16253523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions.
    Wilson HC; Scolding NJ; Raine CS
    J Neuroimmunol; 2006 Jul; 176(1-2):162-73. PubMed ID: 16753227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased NG2(+) glial cell proliferation and oligodendrocyte generation in the hypomyelinating mutant shiverer.
    Bu J; Banki A; Wu Q; Nishiyama A
    Glia; 2004 Oct; 48(1):51-63. PubMed ID: 15326615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse.
    Ughrin YM; Chen ZJ; Levine JM
    J Neurosci; 2003 Jan; 23(1):175-86. PubMed ID: 12514214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro.
    Asher RA; Morgenstern DA; Properzi F; Nishiyama A; Levine JM; Fawcett JW
    Mol Cell Neurosci; 2005 May; 29(1):82-96. PubMed ID: 15866049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocan and phosphacan: two major nervous tissue-specific chondroitin sulfate proteoglycans.
    Margolis RK; Rauch U; Maurel P; Margolis RU
    Perspect Dev Neurobiol; 1996; 3(4):273-90. PubMed ID: 9117260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2.
    Fidler PS; Schuette K; Asher RA; Dobbertin A; Thornton SR; Calle-Patino Y; Muir E; Levine JM; Geller HM; Rogers JH; Faissner A; Fawcett JW
    J Neurosci; 1999 Oct; 19(20):8778-88. PubMed ID: 10516297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NG2 proteoglycan expression in the peripheral nervous system: upregulation following injury and comparison with CNS lesions.
    Rezajooi K; Pavlides M; Winterbottom J; Stallcup WB; Hamlyn PJ; Lieberman AR; Anderson PN
    Mol Cell Neurosci; 2004 Apr; 25(4):572-84. PubMed ID: 15080887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface.
    Nishiyama A; Stallcup WB
    Mol Biol Cell; 1993 Nov; 4(11):1097-108. PubMed ID: 8305732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-syndecan: structure and function of a transmembrane heparan sulfate proteoglycan.
    Carey DJ
    Perspect Dev Neurobiol; 1996; 3(4):331-46. PubMed ID: 9117264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NG2-positive cells in CNS function and the pathological role of antibodies against NG2 in demyelinating diseases.
    Trotter J
    J Neurol Sci; 2005 Jun; 233(1-2):37-42. PubMed ID: 15949494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase of NG2-positive cells associated with radial glia following traumatic spinal cord injury in adult rats.
    Wu D; Shibuya S; Miyamoto O; Itano T; Yamamoto T
    J Neurocytol; 2005 Dec; 34(6):459-69. PubMed ID: 16902766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers. Abnormal expression in merosin-negative and Duchenne muscular dystrophies.
    Petrini S; Tessa A; Carrozzo R; Verardo M; Pierini R; Rizza T; Bertini E
    Mol Cell Neurosci; 2003 Jun; 23(2):219-31. PubMed ID: 12812755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.